About Nemysis
Nemysis is a company based in Dublin (Ireland) founded in 2015 by Danilo Casadei Massari. Nemysis has raised $4.1 million across 5 funding rounds from investors including Aviapharma and EIC Fund. Nemysis offers products and services including IHAT, E40, and Novel Delivery Matrix. Nemysis operates in a competitive market with competitors including Kapiva, ChromaDex, Labomar, Setu and BBetter, among others.
- Headquarter Dublin, Ireland
- Founders Danilo Casadei Massari
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nemysis Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.1 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
Aviapharma
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nemysis
Nemysis offers a comprehensive portfolio of products and services, including IHAT, E40, and Novel Delivery Matrix.
Treats iron deficiency by mimicking natural absorption to reduce side effects.
Breaks down gluten peptides for patients with sensitivities.
Provides gastro-protection for compounds targeting the intestines.
People of Nemysis
Unlock access to complete
Unlock access to complete
Funding Insights of Nemysis
Nemysis has successfully raised a total of $4.1M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nemysis
Nemysis has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Aviapharma and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Developer and distributor of own and licensed pharmaceutical products
|
Locked | Locked | Locked |
Investor details for Nemysis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nemysis
Investment portfolio details for Nemysis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nemysis
Detailed financials for Nemysis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nemysis Comparisons
Peer comparison for Nemysis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nemysis
Nemysis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, ChromaDex, Labomar, Setu and BBetter, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| Locked | Locked | Locked |
Nutritional ingredients for health and wellness are developed.
|
|
| Locked | Locked | Locked |
Dietary supplements, diet foods, health products, and medical devices
|
|
| Locked | Locked | Locked |
Dietary supplements with herbal extracts and vitamins are provided.
|
|
| Locked | Locked | Locked |
Nutritional supplements are provided to enhance health and wellness.
|
|
| Locked | Locked | Locked |
Nutritional products for various health ailments are provided.
|
Detailed competitors of Nemysis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nemysis
Complete news archive for Nemysis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nemysis
Nemysis was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Nemysis is headquartered in Dublin, Ireland.
Danilo Casadei Massari is the current CEO of Nemysis. They have also founded this company.
Nemysis is a funded company, having raised a total of $4.1M across 5 funding rounds to date.
Nemysis was founded in 2015 in Dublin, Ireland, within the pharmaceutical sector. Focus is placed on creating nano-particulate food supplements to address micro-deficiency diseases, particularly iron deficiency and anemia. Solutions for gluten intolerance are also offered. Operations center on research and development of these treatments. The company was acquired by ExPharma Limited, with its domain registered as nemysisltd.com. Leadership is provided by founder and CEO Danilo Casadei Massari.
Nemysis offers IHAT, E40, and Novel Delivery Matrix.
Nemysis has 2 investors. Key investors include Aviapharma, and EIC Fund.